2019 Annual Meeting | C91 - Neurology Update III: Headache, Neuro-otology, and Epilepsy
Date
Monday 05/06/19
Time
01:00 PM - 03:00 PM EDT
Add To Calendar
Session Format
This program will be presented both in-person and online
On Demand
This program is not expected to be available in the meeting's On Demand product.
Event Type
Seminar
Director(s)
Adam Quick, MD, Ralph F. Jozefowicz, MD, FAAN
Topic(s)
Epilepsy/Clinical Neurophysiology (EEG), Headache, Neuro-ophthalmology/Neuro-otology, General Neurology: Overview
Learning Objectives
Participants should understand the indications for newly available headache treatments and how to apply them, discern the common causes of vestibular disfunction and how to differentiate peripheral from central causes of vertigo and imbalance, and recognize and treat the common seizure disorders.
CME Available
2.00 CME credits
Core Competencies
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Program Level
Intermediate
Program Tracks
Advanced Practice Provider
Recommended Audience
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Teaching Styles
Didactic
Program Materials
Program Evaluations
Event Timeline
01:00 PM - 01:40 PM EDT
Speaker
Update in Headache
01:40 PM - 02:20 PM EDT
Speaker
Update in Neuro-otology
02:20 PM - 03:00 PM EDT
Speaker
Update in Epilepsy
Faculty Disclosures
Christopher J. Boes, MD, FAAN
Dr. Boes has nothing to disclose.
Ralph F. Jozefowicz, MD, FAAN
Dr. Jozefowicz has nothing to disclose.
Adam Quick, MD
The institution of Dr. Quick has received research support from NINDS. The institution of Dr. Quick has received research support from NEALS.
Gregory K. Bergey, MD, FAAN
Dr. Bergey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics.
Terry D. Fife, MD, FAAN
Dr. Fife has nothing to disclose.